Cybin (HELP) Research & Development (2020 - 2025)
Cybin (HELP) reported Research & Development of $10822.1 for Q2 2025, up 151.86% on a YoY basis from $4296.9 in Q2 2024, and down 99.97% quarter-over-quarter from $38.2 million in Q1 2025.
Cybin (HELP) Research & Development (2020 - 2025) Analysis & Trends
Cybin has reported Research & Development for 6 years, with the latest figure at $10822.1 in Q2 2025.
- For the quarter ending Q2 2025, Research & Development rose 151.86% year-over-year to $10822.1; the trailing twelve-month figure through Jun 2025 stood at $44.9 million (up 54.97% YoY), and the FY2025 full-year result was $39.5 million, up 64.47% from the prior year.
- Research & Development for Q2 2025 stood at $10822.1, down from $38.2 million in the prior quarter.
- The five-year high for Research & Development was $38.2 million in Q1 2025, with the low at -$278040.9 in Q1 2023.
- Historically, Research & Development has averaged $5.8 million across 5 years, with a median of $3.0 million in 2021.
- Annual changes were most pronounced in 2021 — Research & Development soared 829.15% — and 2024, when it plunged 99.91%.
- Cybin's Research & Development stood at $3.9 million in 2021, then increased by 17.05% to $4.6 million in 2022, then tumbled by 99.88% to $5464.2 in 2023, then surged by 146.1% to $13447.2 in 2024, then slipped by 19.52% to $10822.1 in 2025.
- The last three Research & Development figures came in at $10822.1 (Q2 2025), $38.2 million (Q1 2025), and $13447.2 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | 10,822.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 10,822.08 |
| Mar 31, 2025 | 38.24 Mn |
| Dec 31, 2024 | 13,447.23 |
| Sep 30, 2024 | 6.68 Mn |
| Jun 30, 2024 | 4,296.91 |
| Mar 31, 2024 | 24.00 Mn |
| Dec 31, 2023 | 5,464.21 |
| Sep 30, 2023 | 4.99 Mn |
| Jun 30, 2023 | 4.75 Mn |
| Feb 28, 2023 | -278,040.91 |
| Dec 31, 2022 | 4.61 Mn |
| Sep 30, 2022 | 3.94 Mn |
| May 31, 2022 | 1.64 Mn |
| Dec 31, 2021 | 3.94 Mn |
| Sep 30, 2021 | 3.03 Mn |
| Jun 30, 2021 | 2.42 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Dec 31, 2020 | 572,989.83 |
| Sep 30, 2020 | 326,434.30 |
| Jun 30, 2020 | 508,448.78 |